Diffuse Large Cell Lymphoma Recruiting Phase 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0031285 (Diffuse Large Cell Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01859819Treatment for Advanced B-Cell LymphomaTreatment